WallStSmart
GRTS

Gritstone Oncology Inc

NASDAQ: GRTS · HEALTHCARE · BIOTECHNOLOGY

$0.03
+0.00% today

Updated 2026-04-30

Market cap
$3.80M
P/E ratio
—
P/S ratio
0.26x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$0 – $0
Volume
—
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Gritstone Oncology Inc (GRTS) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20162017201820192020202120222023
Revenue$0.00$0.00$1.19M$4.37M$4.04M$46.72M$9.27M$1.33M
Revenue growth (YoY)———+267.7%-7.5%+1057.2%-80.2%-85.6%
Cost of revenue$13.92M$35.69M$54.97M$82.90M$88.64M$14.40M$15.69M$7.59M
Gross profit$-13.92M$-35.69M$1.19M$-78.53M$-84.61M$32.32M$-6.42M$-6.26M
Gross margin——100.0%-1799.1%-2095.8%69.2%-69.3%-470.3%
R&D$13.92M$35.69M$54.97M$82.90M$88.64M$97.49M$111.40M$127.18M
SG&A$5.06M$6.07M$11.81M$19.41M$21.41M$25.93M$28.97M$28.78M
Operating income$-18.98M$-41.76M$-65.58M$-97.94M$-106.02M$-75.21M$-120.43M$-154.63M
Operating margin——-5525.2%-2243.8%-2626.1%-161.0%-1299.3%-11617.9%
EBITDA$-18.16M$-39.79M$-61.62M$-93.19M$-98.67M$-68.70M$-111.89M$-126.86M
EBITDA margin——-5191.5%-2135.1%-2444.1%-147.1%-1207.2%-9531.4%
EBIT$-18.98M$-41.76M$-65.58M$-97.94M$-105.31M$-83.10M$-127.58M$-134.45M
Interest expense$0.00$0.00$0.00$0.00$12000.00$37000.00$1.24M$4.04M
Income tax————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-18.75M$-41.38M$-64.78M$-90.93M$-104.61M$-74.95M$-113.13M$-138.49M
Net income growth (YoY)—-120.7%-56.5%-40.4%-15.1%+28.3%-50.9%-22.4%
Profit margin——-5457.0%-2083.1%-2591.3%-160.4%-1220.5%-10405.0%